DIREVO Industrial Biotechnology
Cologne
About DIREVO Industrial Biotechnology
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $51.6M
- Funding stage: M&A
- Last round: Series D (Apr 2010)
- Website: direvo.com
- Phone: 49 221-47448-0
Industries & Categories
Biomass Energy, Biotechnology, Industrial
Social Profiles
Canonical: https://fsome.com/organization/direvo-industrial-biotechnology-1208757 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.